| Basics |
Masimo Corporation Common Stock
Masimo Corp is a medical technology company. The company develops, manufactures, and markets noninvasive monitoring technologies. Its product includes noninvasive blood constituent and brain and breath monitoring.
|
| IPO Date: |
August 8, 2007 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$7.61B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.30 | 1.43%
|
| Avg Daily Range (30 D): |
$2.68 | 1.84%
|
| Avg Daily Range (90 D): |
$2.47 | 1.67%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.44M |
| Avg Daily Volume (30 D): |
.66M |
| Avg Daily Volume (90 D): |
.62M |
| Trade Size |
| Avg Trade Size (Sh.): |
72 |
| Avg Trade Size (Sh.) (30 D): |
43 |
| Avg Trade Size (Sh.) (90 D): |
42 |
| Institutional Trades |
| Total Inst.Trades: |
8,689 |
| Avg Inst. Trade: |
$5.01M |
| Avg Inst. Trade (30 D): |
$7.93M |
| Avg Inst. Trade (90 D): |
$7.66M |
| Avg Inst. Trade Volume: |
.05M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$7.72M |
| Avg Closing Trade (30 D): |
$13.28M |
| Avg Closing Trade (90 D): |
$13.19M |
| Avg Closing Volume: |
62.65K |
|
|
| Financials |
| |
TTM |
Q3 2026 |
Q2 2026 |
|
Basic EPS
|
$-10.63
|
$-1.86
|
$.95
|
|
Diluted EPS
|
$-10.56
|
$-1.84
|
$.94
|
|
Revenue
|
$ 2.18B
|
$ 371.5M
|
$ 370.9M
|
|
Gross Profit
|
$ 1.08B
|
$ 230.6M
|
$ 233.3M
|
|
Net Income / Loss
|
$ -569.4M
|
$ -100.4M
|
$ 51.3M
|
|
Operating Income / Loss
|
$ -173.9M
|
$ 83.6M
|
$ 64.5M
|
|
Cost of Revenue
|
$ 1.11B
|
$ 140.9M
|
$ 137.6M
|
|
Net Cash Flow
|
$ 151.7M
|
$ 118.3M
|
$
|
|
PE Ratio
|
|
|
|
|
|
|
